Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:1092-1098

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasunari, K.
Right arrow Articles by Yoshikawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasunari, K.
Right arrow Articles by Yoshikawa, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
*RHODANINE
Related Collections
Right arrow Remodeling
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Cell signalling/signal transduction

(Hypertension. 2000;35:1092.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Aldose Reductase Inhibitor Improves Insulin-Mediated Glucose Uptake and Prevents Migration of Human Coronary Artery Smooth Muscle Cells Induced by High Glucose

Kenichi Yasunari; Masakazu Kohno; Hiroaki Kano; Mieko Minami; Junichi Yoshikawa

From the First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.

Correspondence to Kenichi Yasunari, MD, First Department of Internal Medicine, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, Osaka 545-8586, Japan.

Abstract—We examined involvement of the polyol pathway in high glucose–induced human coronary artery smooth muscle cell (SMC) migration using Boyden’s chamber method. Chronic glucose treatment for 72 hours potentiated, in a concentration-dependent manner (5.6 to 22.2 mol/L), platelet-derived growth factor (PDGF) BB–mediated SMC migration. This potentiation was accompanied by an increase in PDGF BB binding, because of an increased number of PDGF-ß receptors, and this potentiation was blocked by the aldose reductase inhibitor epalrestat. Epalrestat at concentrations of 10 and 100 nmol/L inhibited high glucose–potentiated (22.2 mmol/L), PDGF BB–mediated migration. Epalrestat at 100 nmol/L inhibited a high glucose–induced increase in the reduced/oxidized nicotinamide adenine dinucleotide ratio and membrane-bound protein kinase C (PKC) activity in SMCs. PKC inhibitors calphostin C (100 nmol/L) and chelerythrine (1 µmol/L) each inhibited high glucose–induced, PDGF BB–mediated SMC migration. High glucose–induced suppression of insulin-mediated [3H]-deoxyglucose uptake, which was blocked by both calphostin C (100 nmol/L) and chelerythrine (1 µmol/L), was decreased by epalrestat (100 nmol/L). Chronic high glucose treatment for 72 hours increased intracellular oxidative stress, which was directly measured by flow cytometry using carboxydichlorofluorescein diacetate bis-acetoxymethyl ester, and this increase was significantly suppressed by epalrestat (100 nmol/L). Antisense oligonucleotide to PKC-ß isoform inhibited high glucose–mediated changes in SMC migration, insulin-mediated [3H]-deoxyglucose uptake, and oxidative stress. These findings suggest that high glucose concentrations potentiate SMC migration in coronary artery and that the aldose reductase inhibitor epalrestat inhibits high glucose–potentiated, PDGF BB–induced SMC migration, possibly through suppression of PKC (PKC-ß), impaired insulin-mediated glucose uptake, and oxidative stress.


Key Words: pathway, polyol • protein kinases • oxidative stress • insulin resistance • atherosclerosis




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava
Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth
Endocrinology, September 1, 2007; 148(9): 4371 - 4384.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Campbell and E. R. Trimble
Modification of PI3K- and MAPK-Dependent Chemotaxis in Aortic Vascular Smooth Muscle Cells by Protein Kinase C{beta}II
Circ. Res., February 4, 2005; 96(2): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Campbell, W. E. Allen, J. A. Silversides, and E. R. Trimble
Glucose-Induced Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase-Dependent Upregulation of the Platelet-Derived Growth Factor-{beta} Receptor Potentiates Vascular Smooth Muscle Cell Chemotaxis
Diabetes, February 1, 2003; 52(2): 519 - 526.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Slevin, S. Kumar, and J. Gaffney
Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing Responses
J. Biol. Chem., October 18, 2002; 277(43): 41046 - 41059.
[Abstract] [Full Text] [PDF]